FDA Enables Treatment For Thyroid Eye Disease
Yesterday the U.S. Food and Drug Administration (FDA) accepted Tepezza (teprotumumab-trow) for the processing of adults with a thyroid eye disorder, a rare condition where…
Yesterday the U.S. Food and Drug Administration (FDA) accepted Tepezza (teprotumumab-trow) for the processing of adults with a thyroid eye disorder, a rare condition where…